PROK
NASDAQ
US
ProKidney Corp. - Class A Ordinary Shares
$1.90
▲ +$0.15
(+8.57%)
Vol 1.1M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$673.9M
ROE
-28.1%
Margin
-9547.5%
D/E
540.00
Beta
1.93
52W
$0–$7
Wall Street Consensus
15 analysts · Apr 20265
Strong Buy
5
Buy
4
Hold
1
Sell
0
Strong Sell
66.7%
Buy Rating
Price Chart
Similar Stocks
ALLO
Allogene Therapeutics Inc
$307.9M
PRME
Prime Medicine Inc
$626.4M
OCGN
Ocugen Inc
$421.6M
MDXG
MiMedx Group Inc
P/E 24.6
$1.0B
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
TECX
Tectonic Therapeutic Inc
$390.4M
KYTX
Kyverna Therapeutics Inc
$537.0M
EIKN
Eikon Therapeutics Inc
CBIO
Crescent Biopharma Inc
$164.8M
ZURA
Zura Bio Ltd
$340.7M
Earnings
Beat rate: 60.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.12 | $-0.14 | $-0.02 |
| Sep 2025 | $-0.13 | $-0.12 | +$0.01 |
| Jun 2025 | $-0.15 | $-0.13 | +$0.02 |
| Mar 2025 | $-0.16 | $-0.13 | +$0.03 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -28.1% | -28.1% | -28.1% | -28.1% | -28.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -7489.6% | — | — | — | -9547.5% | -9547.5% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | 540.00 | 540.00 | 540.00 | 540.00 | 540.00 |
| Current Ratio | 11.48 | 11.48 | 11.48 | 11.48 | 10.32 | 10.32 |
Key Ratios
ROA (TTM)
-18.1%
P/S (TTM)
905.74
EPS (TTM)
$-0.54
CF/Share
$-2.16
52W High
$7.13
52W Low
$0.46
$0.46
52-Week Range
$7.13
How does PROK compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PROK valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
905.7
▲
6949%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PROK profitability vs Biotechnology peers
ROE
-28.1%
▲
58%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-9547.5%
▼
3230%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-18.1%
▲
61%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PROK financial health vs Biotechnology peers
D/E ratio
540.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
10.3
▲
132%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.9
▲
99%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PROK fundamentals radar
PROK
Peer median
Industry
PROK profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio